Drug Discovery Informatics Market Size, Top Players, and Forecast by 2031
Drug Discovery Informatics Market: Size and Share
-
CAGR (2023 - 2031)13.0% -
Market Size 2023
US$ 3.07 Billion -
Market Size 2031
US$ 8.17 Billion
Market Dynamics
- Advancements in bioinformatics and AI
- Increasing need for drug development efficiency and reduced time-to-market
- Integration of AI and big data for drug discovery
- Demand for faster and cost-effective drug development processes
- Increased investments in drug discovery and personalized medicine creating opportunities for informatics solutions
- Growing demand for faster and more accurate drug development processes
Market Segmentation
- Discovery Informatics and Drug Development
- Sequence Analysis Platform
- Molecular Modeling
- Clinical Trial Data Management
- Docking
- Software and Services
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
Drug Discovery Informatics Market Players Density: Understanding Its Impact on Business Dynamics
The Drug Discovery Informatics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Drug Discovery Informatics Market are:
- Certara
- Infosys Ltd.
- Collaborative Drug Discovery, Inc.
- Jubliant Biosys
- Curia Global, Inc.
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Drug Discovery Informatics Market top key players overview